Maryland biotech with N.C. ties files to go public

A Maryland based biotech with North Carolina ties has filed to go public: Intrexon Corporation. The synthetic biology company, which launched its Agricultural Biotechnology Division in Research Triangle Park after acquiring local company Agarigen in 2011, has a 32,000-square-foot research and development facility in Durham...